| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Ratings for Enovix (NASDAQ:ENVX) were provided by 5 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 2 | 3 | 0 | 0 | 0 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 0 | 1 | 0 | 0 | 0 |
| 2M Ago | 0 | 0 | 0 | 0 | 0 |
| 3M Ago | 2 | 1 | 0 | 0 | 0 |
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $22.6, with a high estimate of $30.00 and a low estimate of $12.00. Witnessing a positive shift, the current average has risen by 25.56% from the previous average price target of $18.00.
The standing of Enovix among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Bill Peterson | JP Morgan | Lowers | Overweight | $12.00 | $18.00 |
| Derek Soderberg | Cantor Fitzgerald | Maintains | Overweight | $30.00 | - |
| Tim Moore | EF Hutton | Maintains | Buy | $24.00 | - |
| Derek Soderberg | Cantor Fitzgerald | Maintains | Overweight | $30.00 | - |
| George Gianarikas | Canaccord Genuity | Maintains | Buy | $17.00 | - |
For valuable insights into Enovix's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
Stay up to date on Enovix analyst ratings.
If you are interested in following small-cap stock news and performance you can start by tracking it here.
Enovix Corp is engaged in the business of advanced silicon-anode lithium-ion battery development and production. It is also developing its 3D cell technology and production process for the electric vehicle and energy storage markets to help enable the widespread utilization of renewable energy.
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: Enovix's remarkable performance in 3 months is evident. As of 31 December, 2023, the company achieved an impressive revenue growth rate of 575.3%. This signifies a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Industrials sector.
Net Margin: Enovix's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of -812.59%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Enovix's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of -23.49%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Enovix's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of -11.06%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: Enovix's debt-to-equity ratio is notably higher than the industry average. With a ratio of 0.74, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: ENVX
